SCHEMBL2478099

SCHEMBL2478099

O=C(NS(=O)(=O)c1ccc(NC2CCN(CI)CC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(CC3=C(c4ccc(Cl)cc4)CCCC3)CC2)cc1Oc1ccccc1Cl

nearest known ligand 0.89

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 15/20 0.89

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1958762 0.94 BCL2 (1.00) BCL2
SCHEMBL1955125 0.93 BCL2 (1.00) BCL2
SCHEMBL1957695 0.87 BCL2 (1.00) BCL2
SCHEMBL1958185 0.86 BCL2 (1.00) BCL2
SCHEMBL1960384 0.86 BCL2 (1.00) BCL2
SCHEMBL1959715 0.85 BCL2 (1.00) BCL2
SCHEMBL1956732 0.85 BCL2 (1.00) BCL2
SCHEMBL1960329 0.85 BCL2 (1.00) BCL2
SCHEMBL1955432 0.85 BCL2 (0.83) BCL2
SCHEMBL1958573 0.85 BCL2 (1.00) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2376197-A2 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Abbott Laboratories (US) 2011-10-19 — — EP disclosed
WO-2010065824-A2 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LABORATORIES (US) 2010-06-10 — — WO disclosed
Send feedback